← Browse by Condition

Medical Condition

obsessive compulsive disorder

Total Trials

11

Recruiting Now

11

Trial Phases

Phase 2

Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder

Medical University of Vienna

NCT04899687 Phase 2

Study of Dextromethorphan in OCD and Related Disorders

Stanford University

Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder

University of British Columbia

NCT04882839 Phase 2

Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD

Beersheva Mental Health Center

Neurosurgical Outcome Network

Fondazione I.R.C.C.S. Istituto...

Neurostimulation Versus Therapy for Problems With Emotions

Duke University

NCT05940324 Phase 2

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Stanford University

Individually Targeted Neuromodulation for Contamination-based OCD

Mclean Hospital

Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder

Uppsala University Hospital

Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder

Susanne Walitza

tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder

Centre Hospitalier Henri Labor...